NCT00120172View on ClinicalTrials.gov

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

June 30, 2006

Conditions

Colorectal CancerNeoplasm Metastasis

Interventions

DRUG

oxaliplatin, capecitabine, bevacizumab

Trial Locations (5)

20007

Washington D.C.

34452

Inverness

34652

New Port Richey

83814

Coeur d'Alene

91345

Mission Hills

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

Geriatric Oncology Consortium

OTHER